MDBOMultilateral Development Bank Operations
References in periodicals archive ?
MDBO examines the scenarios which may play out over the next three years at the product, drug portfolio and company level, taking into account variables such as Part D enrollment and cost containment strategies.
Unlike other analyses that stress the cost of the drug benefit to the taxpayer, MDBO projects revenue forecasts for individual products during the critical time period from 2006 to 2008.